MECLIZINE 12.5 MG TABLET

What it is

MECLIZINE 12.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “meclizine” and “meclizine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Meclizine HCl”.

FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.

FDA lists 13 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Rising Pharma Holdings, Inc. and APNAR PHARMA LP.

FDA’s Established Pharmacologic Class for it is Antiemetic.

The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 20 of them.

NADAC classes it as a generic drug (rate-setting class G), and marks some of its NDCs as sold over the counter and some not.

What pharmacies pay

Pharmacies pay $0.94 – $1.33 for 30 tablets, depending on the NDC ($0.03127 to $0.04419 per EA), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 13 labelers

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with MECLIZINE 12.5 MG TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 23 NDCs’ NADAC prices is $0.04419 per EA filed.

Of the 10 other products in FDA’s Antiemetic class priced per EA, 4 have a higher middle NADAC price and 6 a lower one. The one in the middle is MOTION-TIME 25 MG TABLET CHEW, at $0.03334 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $4.43 for 30 tablets, at an average of $0.1477 per EA in 2024 (2024-01-01 to 2024-12-31) for “Meclizine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,025,148 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

20 of the product’s 23 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.03127 to $0.04419 per EA for this product, depending on the NDC.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.